169 related articles for article (PubMed ID: 7348572)
1. Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.
Murray RM; Pitt P
Breast Cancer Res Treat; 1981; 1(2):91-5. PubMed ID: 7348572
[TBL] [Abstract][Full Text] [Related]
2. Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
Murray RM; Pitt P
Cancer Res; 1982 Aug; 42(8 Suppl):3437s-3441s. PubMed ID: 6211229
[TBL] [Abstract][Full Text] [Related]
3. The treatment of metastatic breast cancer with aminoglutethimide.
Kaye SB; Woods RL; Fox RM; Tattersall MH
Aust N Z J Med; 1981 Aug; 11(4):370-4. PubMed ID: 7030292
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
Smith IE; Harris AL; Morgan M; Ford HT; Gazet JC; Harmer CL; White H; Parsons CA; Villardo A; Walsh G; McKinna JA
Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1432-4. PubMed ID: 6797571
[TBL] [Abstract][Full Text] [Related]
6. Response to aminoglutethimide after failure of tamoxifen therapy in breast cancer.
Sutherland CM; Muchmore JH; Carter RD
South Med J; 1985 Aug; 78(8):987-9. PubMed ID: 4023793
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
Bezwoda WR; Derman DP; Browde S; Goss G; Lange M
S Afr Med J; 1984 Sep; 66(10):372-4. PubMed ID: 6484759
[TBL] [Abstract][Full Text] [Related]
8. Metastatic breast cancer in males. Assessment of endocrine therapy.
Patel JK; Nemoto T; Dao TL
Cancer; 1984 Mar; 53(6):1344-6. PubMed ID: 6198069
[TBL] [Abstract][Full Text] [Related]
9. Second line hormonal therapy with aminoglutethimide in metastatic breast cancer.
Brufman G; Biran S
Acta Oncol; 1990; 29(6):717-20. PubMed ID: 2223141
[TBL] [Abstract][Full Text] [Related]
10. Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
Boccardo F; Rubagotti A; Amoroso D; Mesiti M; Romeo D; Caroti C; Farris A; Cruciani G; Villa E; Schieppati G; Mustacchi G;
J Clin Oncol; 2001 Nov; 19(22):4209-15. PubMed ID: 11709564
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
[TBL] [Abstract][Full Text] [Related]
12. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
14. Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatments.
Zambetti M; Brambilla C; Tancini G; Bonadonna G
Tumori; 1987 Aug; 73(4):369-73. PubMed ID: 3660475
[TBL] [Abstract][Full Text] [Related]
15. Could aminoglutethimide replace adrenalectomy?
Harris AL
Breast Cancer Res Treat; 1985; 6(3):201-11. PubMed ID: 3912013
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
Holdaway IM
Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
[TBL] [Abstract][Full Text] [Related]
17. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal control of disseminated breast cancer].
Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu
Sov Med; 1990; (6):94-7. PubMed ID: 2144368
[No Abstract] [Full Text] [Related]
19. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
Brufman G; Biran S
Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
[TBL] [Abstract][Full Text] [Related]
20. [Hormone therapy of patients with breast cancer].
Moiseenko VM; Semiglazov VF
Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
